Argent Capital Management LLC lifted its stake in Hamilton Lane Inc. (NASDAQ:HLNE - Free Report) by 207.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,508 shares of the company's stock after purchasing an additional 24,618 shares during the period. Argent Capital Management LLC owned about 0.07% of Hamilton Lane worth $5,189,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of HLNE. MassMutual Private Wealth & Trust FSB lifted its holdings in Hamilton Lane by 252.0% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 176 shares of the company's stock worth $26,000 after buying an additional 126 shares during the last quarter. WPG Advisers LLC purchased a new stake in Hamilton Lane during the 1st quarter worth about $26,000. Versant Capital Management Inc acquired a new stake in shares of Hamilton Lane during the first quarter worth about $30,000. Whittier Trust Co. of Nevada Inc. acquired a new stake in shares of Hamilton Lane during the first quarter worth about $33,000. Finally, Geneos Wealth Management Inc. increased its position in shares of Hamilton Lane by 196.9% during the first quarter. Geneos Wealth Management Inc. now owns 383 shares of the company's stock worth $57,000 after purchasing an additional 254 shares in the last quarter. 97.40% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Hamilton Lane
In related news, major shareholder River 5 Ltd French sold 150,000 shares of the company's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $146.51, for a total value of $21,976,500.00. Following the sale, the insider owned 330,015 shares of the company's stock, valued at approximately $48,350,497.65. This represents a 31.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 22.21% of the company's stock.
Hamilton Lane Price Performance
Shares of NASDAQ:HLNE opened at $149.15 on Tuesday. The business's 50 day simple moving average is $152.56 and its 200-day simple moving average is $150.52. The firm has a market capitalization of $8.30 billion, a price-to-earnings ratio of 28.68 and a beta of 1.26. The company has a debt-to-equity ratio of 0.29, a current ratio of 4.32 and a quick ratio of 4.32. Hamilton Lane Inc. has a 12 month low of $124.10 and a 12 month high of $203.72.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.31 EPS for the quarter, topping the consensus estimate of $0.98 by $0.33. Hamilton Lane had a return on equity of 29.47% and a net margin of 30.66%.The business had revenue of $196.73 million for the quarter, compared to analyst estimates of $166.96 million. During the same quarter in the previous year, the company earned $1.47 EPS. The company's quarterly revenue was up 11.8% on a year-over-year basis. As a group, equities analysts forecast that Hamilton Lane Inc. will post 4.97 earnings per share for the current fiscal year.
Hamilton Lane Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, October 6th. Investors of record on Friday, September 19th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Friday, September 19th. This represents a $2.16 dividend on an annualized basis and a yield of 1.4%. Hamilton Lane's dividend payout ratio is presently 41.54%.
Analysts Set New Price Targets
A number of research firms have recently commented on HLNE. The Goldman Sachs Group upgraded Hamilton Lane from a "sell" rating to a "neutral" rating and lifted their target price for the stock from $149.00 to $162.00 in a research report on Thursday, September 18th. JPMorgan Chase & Co. cut their target price on Hamilton Lane from $153.00 to $145.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 23rd. Keefe, Bruyette & Woods lifted their target price on Hamilton Lane from $160.00 to $168.00 and gave the stock a "market perform" rating in a research report on Wednesday, August 6th. Wall Street Zen cut Hamilton Lane from a "hold" rating to a "sell" rating in a research report on Saturday. Finally, Wells Fargo & Company lifted their target price on Hamilton Lane from $161.00 to $162.00 and gave the stock an "equal weight" rating in a research report on Friday, July 11th. Seven research analysts have rated the stock with a Hold rating, According to MarketBeat, Hamilton Lane presently has a consensus rating of "Hold" and a consensus target price of $166.43.
View Our Latest Stock Report on HLNE
About Hamilton Lane
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.